Health
Value of low cholesterol questioned
NEWS IN BRIEF — Posted Oct. 23, 2006
The National Cholesterol Education Program recommends physicians attempt to lower the LDL cholesterol of patients at very high risk of heart disease to less than 70 mg/dL. Still, little evidence shows that these efforts, which usually require several different types of drugs, translate into reductions in cardiovascular disease, according to a review in the October Annals of Internal Medicine. The authors did say, however, that evidence is ample to recommend statins for this patient population.
"Current practice guidelines and recommendations often focus on getting LDL as low as possible, but the literature to date doesn't demonstrate that low LDL is what is truly important," said Rodney Hayward, MD, lead author and director of the VA Center for Health Services Research and Development in Ann Arbor, Mich. "But it does show that statins save lives in high cardiac risk patients regardless of a person's LDL level."
The authors are calling for large-scale clinical trials investigating the safety and efficacy of multidrug therapy commonly used to reach these targets. Meanwhile, they recommend that high-risk patients be prescribed the highest doses of statin drugs they can tolerate, regardless of LDL levels.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/10/23/hlbf1023.htm.












